The atrioventricular node, usually called the AV node, is a small cluster of specialized heart cells that serves as the sole electrical bridge between the upper and lower chambers of your heart. It sits near the center of the heart, at the base of the atrial septum, and its main job is to slow down electrical signals just long enough for the upper chambers (atria) to finish contracting before the lower chambers (ventricles) take over. Without it, the ventricles would fire too soon, too fast, or not at all, and the heart’s pumping efficiency would collapse. The AV node also acts as a critical safety filter, blocking dangerously rapid signals from ever reaching the ventricles.
Where Exactly Is the AV Node
The AV node lives in a region called the triangle of Koch, a small anatomical landmark on the right side of the heart’s interior, near the junction of the atria and ventricles. It sits just above the attachment of the tricuspid valve’s septal leaflet. From there, it transitions into the penetrating bundle (the bundle of His), which carries the electrical signal through the fibrous tissue that otherwise insulates the atria from the ventricles. In anatomical studies, the lower pole of the AV node consistently sits above the tricuspid septal leaflet, while the upper pole reaches up toward the level of the mitral valve leaflet in about half of examined hearts.1PubMed. Histological topography of the atrioventricular node and its extensions in relation to the cardiothoracic surgical landmarks in normal human hearts
One thing that surprises even some clinicians is how variable the node’s precise position can be from person to person. A study examining both cadaveric hearts and patients found that in just over half of cases, the transition from the AV node to the bundle of His occurred on the atrial side of the tricuspid valve hinge, with further variation relative to the apex of the triangle of Koch.2PubMed. Variable Arrangement of the Atrioventricular Conduction Axis Within the Triangle of Koch: Implications for Permanent His Bundle Pacing That variability matters clinically. Surgeons and electrophysiologists performing procedures near the AV node have to locate it carefully each time rather than assuming it is in a textbook-standard position.
How the AV Node Gets Its Blood Supply
The AV node has its own dedicated artery, called the AV node artery. In about 90% of people, this artery branches off the right coronary artery; in the remaining 10%, it comes from the left coronary artery’s circumflex branch. The artery arises where the coronary vessel curves at the back of the heart, at a landmark called the crux cordis, and it typically measures about 2 mm in diameter.3Journal of International Medical Research. Anatomical Aspects of the Arterial Blood Supply to the Sinoatrial and Atrioventricular Nodes of the Human Heart Which coronary artery feeds the node depends on which artery is “dominant,” meaning which one reaches the crux. A more detailed cadaveric study identified five distinct patterns for where the AV node artery branches off, with the most common pattern (about two-thirds of hearts) being a takeoff from the right coronary artery just past its junction with the inferior interventricular branch.4PubMed Central. Anatomical Study of the Atrioventricular Nodal Branch of the Heart
This anatomy is practical knowledge: a heart attack affecting the right coronary artery can cut off blood flow to the AV node and cause sudden conduction problems, including temporary or permanent heart block.
What the AV Node Actually Does
The AV node performs two functions that are both essential and, in a sense, opposed to each other. First, it deliberately slows down the electrical impulse traveling from the atria to the ventricles. The AV node generates roughly half of the total delay between atrial and ventricular activation.5Pacing and Clinical Electrophysiology. An integrated overview of AV node physiology That pause gives the atria time to squeeze blood into the ventricles before the ventricles contract. When this timing is right, the heart fills efficiently and pumps a full stroke volume with each beat.6EP Europace. Optimization of the atrioventricular delay in sequential and biventricular pacing: physiological bases, critical review, and new purposes
Second, the AV node acts as a protective gatekeeper. If the atria start firing chaotically fast, as they do in atrial fibrillation, the AV node blocks many of those impulses and prevents the ventricles from matching the atrial rate beat for beat.7PubMed. Noninvasive characterization of atrioventricular conduction in patients with atrial fibrillation Without this filtering, a rapid atrial rhythm could push the ventricles into dangerously fast rates, potentially causing ventricular fibrillation and cardiac arrest. The same review of AV node physiology explicitly notes the node “filters atrial impulses that could otherwise induce life-threatening ventricular arrhythmias.”5Pacing and Clinical Electrophysiology. An integrated overview of AV node physiology
Your nervous system also fine-tunes the AV node’s behavior in real time. Both the sympathetic (“fight-or-flight”) and parasympathetic (“rest-and-digest”) branches of the autonomic nervous system influence how quickly signals pass through the node. When researchers blocked both branches with drugs, the variability in conduction time dropped, confirming that the autonomic system continuously adjusts AV node speed alongside the rate set by the sinus node.8PubMed. Rate-related and autonomic effects on atrioventricular conduction assessed through beat-to-beat PR interval and cycle length variability
Why the AV Node Conducts So Slowly
Most heart muscle cells rely on fast sodium channels to generate their electrical signals. The AV node is different. Its cells have very few of those sodium channels. Instead, the electrical upstroke in AV node cells depends primarily on calcium channels, which open and close more slowly. The slow influx of calcium ions through voltage-gated calcium channels gives the AV node its characteristic sluggish electrical signal.9Arrhythmia & Electrophysiology Review. At the Atrioventricular Crossroads: Dual Pathway Electrophysiology in the Atrioventricular Node and its underlying Heterogeneities To put it concretely, the rate of voltage rise in a typical AV node cell is somewhere around 4 to 6 volts per second, compared with 80 to 100 volts per second in ordinary heart muscle cells.9Arrhythmia & Electrophysiology Review. At the Atrioventricular Crossroads: Dual Pathway Electrophysiology in the Atrioventricular Node and its underlying Heterogeneities
This is not a flaw. The slow conduction is exactly what creates the delay the heart needs. It is also why certain drugs work on the AV node: medications that block calcium channels (like verapamil and diltiazem) slow conduction through the node even further, which is useful for controlling heart rate in conditions like atrial fibrillation.
When the AV Node Fails: Heart Block
Problems with AV node conduction show up on an electrocardiogram (ECG) as different degrees of “heart block.” These range from a minor slowdown to a complete disconnection between the atria and ventricles.
- First-degree block: The signal gets through the AV node every time, but it takes longer than normal. On an ECG, the PR interval stretches beyond 200 milliseconds. This is often harmless, though when the delay becomes extreme (above 300 ms), people can develop symptoms resembling pacemaker syndrome, including fatigue and exercise intolerance.10PubMed. First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization
- Second-degree block: Some signals make it through and some do not. There are two classic patterns. In the more common type (Mobitz I or Wenckebach), the delay gradually lengthens until one beat is dropped, then the cycle restarts. This pattern usually originates within the AV node itself and is often benign. The other type (Mobitz II) involves sudden dropped beats without any preceding gradual change in conduction time. Correctly identified Mobitz II block is located below the AV node, in the His-Purkinje system, and typically requires a pacemaker.11PubMed Central. Mobitz type II second-degree atrioventricular block: a commonly overdiagnosed and misinterpreted arrhythmia
- Third-degree (complete) block: No signals cross from the atria to the ventricles at all. The ventricles must rely on an “escape rhythm,” a backup pacemaker that fires on its own at a slower rate. When this escape rhythm originates near the AV node or the bundle of His, the heart rate is relatively stable and the ECG complexes tend to look narrow, similar to a normal beat.12Circulation Research. Correlative electrophysiological and anatomical studies concerning the site of origin of escape rhythm during complete atrioventricular block in the dog When the escape comes from further down the conduction system, it tends to be slower and less reliable, making pacemaker implantation more urgent.
The distinction between block at the level of the AV node versus block below it in the His-Purkinje system is critical for treatment decisions. AV nodal block is often reversible and responsive to medications like atropine; infra-nodal block is more likely to be permanent and more often warrants a pacemaker.
AV Node Reentrant Tachycardia
The AV node is not just a passive relay station: it can become the site of its own arrhythmia. AV nodal reentrant tachycardia (AVNRT) is one of the most common causes of sudden-onset rapid heart rate in otherwise healthy young adults. It happens because the AV node region contains two functionally distinct pathways, a “fast” pathway and a “slow” pathway, with different conduction speeds and recovery times. Under the right conditions, an electrical signal can loop continuously between these two pathways, creating a self-sustaining circuit that drives the heart rate well above normal.
In most cases, catheter ablation of the slow pathway cures AVNRT permanently. An unusual variant uses a slow pathway that connects to the left atrium rather than following the typical route, requiring a different ablation approach to localize the target.13Circulation: Arrhythmia and Electrophysiology. Slow/Fast Atrioventricular Nodal Reentrant Tachycardia Using the Inferolateral Left Atrial Slow Pathway These variants are uncommon, but they illustrate the AV node region’s structural complexity.
Drugs That Target the AV Node
Several widely used cardiac medications work specifically by altering AV node conduction. Calcium channel blockers and beta-blockers slow conduction through the node, making them first-line treatments for controlling ventricular rate in atrial fibrillation. Digoxin does the same, primarily by enhancing vagal (parasympathetic) tone at the node.
Adenosine occupies a special place in AV node pharmacology. Given as a rapid intravenous push, it can temporarily shut down conduction through the AV node for a few seconds, which is often enough to break a reentrant circuit like AVNRT. In laboratory studies, adenosine decreases the duration and amplitude of electrical signals in AV node cells in a dose-dependent manner, and at high concentrations it can render those cells completely unresponsive.14Circulation Research. Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node In clinical practice, the effect is dramatic but fleeting: the drug wears off within seconds, and normal conduction resumes. For patients experiencing AVNRT or other supraventricular tachycardias, adenosine can feel alarming (a brief sensation of the heart stopping) but is generally safe and extremely effective.
The “Ablate and Pace” Strategy
For people with atrial fibrillation whose heart rate cannot be controlled with medications, one option is to deliberately destroy the AV node using radiofrequency catheter ablation and then implant a permanent pacemaker. This “ablate and pace” strategy eliminates the AV node’s ability to transmit chaotic atrial signals to the ventricles, and the pacemaker takes over to keep the ventricles beating at a steady rate.15PubMed. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation
The Ablate and Pace Trial studied 156 patients with symptomatic atrial fibrillation that had not responded to drug therapy. Participants showed improved quality of life and better heart pumping function after the procedure.16PubMed. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation The approach is especially useful for elderly patients or those with severe coexisting illnesses, in whom aggressive drug regimens or complex ablation procedures carry higher risk.17PubMed Central. A review on atrioventricular junction ablation and pacing for heart rate control of atrial fibrillation The trade-off is permanent pacemaker dependence and the ongoing management that comes with it.
How Aging Affects the AV Node
As you get older, the AV node undergoes structural changes that can impair its function. Fat gradually infiltrates the atrial tissue surrounding both the sinus node and the AV node, and fibrous tissue builds up in the ventricular septum near the bundle of His and the bundle branches.18American Heart Journal. The pathologic changes in the conduction system beyond the age of ninety Histological studies have shown that fibrous strands from the central fibrous body begin encroaching into the AV node as early as the first decade of life. By the time someone reaches their thirties, collagen fibers start linking up with the scar tissue around blood vessels, eventually dividing the node’s cellular network into isolated strands.19The Kurume Medical Journal. Pathohistological Changes of Cardiac Conduction Tissue
This progressive fibrosis helps explain why conduction disorders become more common with age. Many elderly people develop first-degree heart block without any obvious heart disease: the AV node simply conducts more slowly as its cellular architecture degrades. It is also one reason why pacemaker implantation rates climb steeply in people over 70.
How the AV Node Develops Before Birth
The AV node does not form from nervous tissue, despite behaving somewhat like a nerve relay. It develops from a specific subpopulation of heart muscle precursor cells in the embryonic atrioventricular canal. These cells differentiate early, and they remain less specialized than the surrounding working heart muscle. They also activate a gene program that is partly “neurogenic,” meaning it shares features with nerve cell development, even though the cells themselves are cardiac in origin.20PubMed. The atrioventricular node: origin, development, and genetic program Different components of the conduction system appear to use distinct developmental strategies, with unique sets of transcription factors guiding each region’s specialization.21Circulation Research. Gene Regulatory Networks in Cardiac Conduction System Development
Understanding this developmental pathway is not purely academic. Congenital heart block, where a baby is born with a nonfunctional or absent AV node connection, sometimes traces back to disruptions in these early gene programs. It also sets the stage for efforts to grow AV node-like cells in the lab.
The AV Node in Evolutionary Perspective
Mammals and birds solve the problem of coordinating atrial and ventricular contraction by growing a sheet of fibrous insulating tissue between the two chambers. The only electrical gap in that insulation is the AV node and its bundle of His. Reptiles do it differently. In studies of the anole lizard, the atrioventricular canal is entirely muscular, with no insulating plane and no discrete AV node. Yet the lizard heart still produces a clear delay between atrial and ventricular contraction.22PLoS ONE. Identifying the Evolutionary Building Blocks of the Cardiac Conduction System Researchers hypothesized that the AV canal tissue in reptiles has a molecular profile that inherently slows conduction, functioning like a primitive AV node without being anatomically separated from the surrounding muscle.
This suggests that the delay mechanism came first, evolutionarily speaking, and the discrete insulated node that mammals use is a later refinement. The AV node as we know it is not the only way nature solved the timing problem; it is just the most precise version of it.
How the AV Node Was Discovered
The AV node was identified in 1905 by Sunao Tawara, a Japanese pathologist working in Ludwig Aschoff’s laboratory in Germany. Tawara traced the bundle of His backward from the ventricles and discovered a compact knot of muscle fibers at the base of the atrial septum. He followed the fibers forward from this knot and showed that they connected through the bundle branches down to the Purkinje fibers in the ventricle walls.23Circulation. Why Does the Heart Beat? This was a watershed moment for cardiology. Tawara recognized the entire structure as a muscle-fiber system responsible for conducting the electrical impulse that makes the heart beat, settling a long-running debate about whether the heartbeat was controlled by nerves or by the muscle itself.24PubMed. The Discovery of the Cardiac Atrioventricular Node by Sunao Tawara and Ludwig Aschoff The node was subsequently named the Aschoff-Tawara node in honor of both researchers. Tawara’s mapping of the conduction system also laid the groundwork for the discovery of the sinus node two years later and, eventually, for the entire field of cardiac electrophysiology.
Biological Pacemakers and the Future
Electronic pacemakers are effective but imperfect. They require battery changes, carry infection risk with every lead that enters the heart, and cannot fully replicate the heart’s natural rate variability in response to exercise and emotion. This has led researchers to explore “biological pacemakers,” using gene therapy or stem cell-derived cells to restore natural pacing function. Several gene therapy strategies aim to convert ordinary heart muscle cells into pacemaker-like cells by introducing genes that encode the ion channels normally found in the sinus or AV nodes.25PubMed Central. Gene Therapy Approaches to Biological Pacemakers
A newer approach focuses specifically on the AV node’s bridging function. Researchers have derived AV node-like pacemaker cells from human stem cells, aiming to create a “biological conduction bridge” that could restore electrical communication between the atria and ventricles in patients with complete heart block.26PubMed. Human pluripotent stem cell-derived atrioventricular node-like pacemaker cells exhibit biological conduction bridge properties These lab-grown cells would theoretically respond to the body’s own autonomic signals the way a native AV node does, speeding up during exercise and slowing down at rest. The work is still in early stages, and no biological pacemaker has reached routine clinical use, but the concept represents one of the more creative intersections of stem cell biology and cardiac electrophysiology.